Pathological Exploration of the Axillary Soft Tissue Microenvironment and Its Impact on Axillary Management and Breast Cancer Outcomes.
George E NaoumOluwadamilola T OladeruHazim AbabnehAmy M ShuiAmy LyAlphonse G TaghianPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Routine reporting of axillary tissue involvement, beyond LNs and ECE, is crucial in predicting breast cancer outcomes. Ruling out the presence of AXT is imperative before any form of axillary de-escalation, especially RLNR omission.
Keyphrases
- lymph node
- sentinel lymph node
- neoadjuvant chemotherapy
- ultrasound guided
- soft tissue
- stem cells
- early stage
- locally advanced
- randomized controlled trial
- squamous cell carcinoma
- type diabetes
- radiation therapy
- emergency department
- clinical trial
- adipose tissue
- study protocol
- rectal cancer
- glycemic control
- insulin resistance
- weight loss
- breast cancer risk
- drug induced